Private Wealth Partners’s AstraZeneca AZN Stock Holding History

Private Wealth Partners’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-10,230	Closed	-$652K	–	132
2015 Q2	$652K	Buy	10,230 +200	+2%	+$13.7K	0.15%	93
2015 Q1	$686K	Sell	10,030 -47,200	-82%	-$3.28M	0.16%	101
2014 Q4	$4.03M	Sell	57,230 -790	-1%	-$56.6K	0.95%	33
2014 Q3	$4.14M	Buy	58,020 +11,320	+24%	+$829K	0.91%	33
2014 Q2	$3.47M	Buy	+46,700	New	+$3.38M	0.76%	38

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Cambiar Investors Denver, Colorado $2.3B AUM 24.77% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

SCCM

Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Private Wealth Partners's AZN Position: Q3 2015 in Review

Private Wealth Partners sold out of AstraZeneca (AZN) in Q3 2015, closing a stake of 10,230 shares — an estimated $652K sold.

Private Wealth Partners first reported a position in AZN in Q2 2014 and held it in 5 quarters. The position peaked at $4.14M in Q3 2014. 371 funds tracked by Wall St. Rank hold AZN as of Q3 2015.

Private Wealth Partners reported no remaining AstraZeneca position as of Q3 2015 after selling out during the quarter.
Private Wealth Partners sold 10,230 AstraZeneca shares in Q3 2015, an estimated $652K.
Private Wealth Partners first reported a position in AstraZeneca in Q2 2014 and held it in 5 quarters.
Private Wealth Partners's AstraZeneca position peaked at $4.14M in Q3 2014.
371 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2015.

Based on Private Wealth Partners's 13F filing for Q3 2015, filed 26 Oct 2015.